Paper Details

  1. Home
  2. Paper Details

How to manage intolerance to dopamine agonist in patients with prolactinoma.

Author: CescatoValter Angelo Sperling, Cunha-NetoMalebranche Berardo Carneiro, GlezerAndrea, MusolinoNina Rosa Castro, PinheiroFelipe Moura Maia, SilvaGilberto Ochman, StumpfMatheo Augusto Morandi

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Dopamine agonists (DA) are the gold-standard for prolactinoma and hyperprolactinemia treatment, but they can cause side effects such as nausea, vomiting, and fatigue. This review discusses DA intolerance and presents a case report concerning the use of intravaginal cabergoline.
Paper Details　
Original Abstract of the Article :
Dopamine agonists (DA) are the gold-standard for prolactinoma and hyperprolactinemia treatment. Intolerance to DA leading to drug drop out occurs in 3 to 12% of cases. We provide here a review of published data about DA intolerance and present a case report concerning the use of intravaginal cabergo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s11102-023-01313-8

データ提供：米国国立医学図書館（NLM）

Managing Dopamine Agonist Intolerance in Prolactinoma Patients

Prolactinomas, benign tumors of the pituitary gland, can cause excessive prolactin production. Dopamine agonists (DA) are the gold-standard treatment for prolactinomas, but some patients experience intolerance. This study explores the challenges of managing DA intolerance and presents a case report on the use of intravaginal cabergoline.

Dopamine Agonist Intolerance: A Challenge in Prolactinoma Treatment

The study highlights the need for alternative treatment options for patients who experience DA intolerance.

Optimizing Prolactinoma Treatment: Personalized Approaches

Managing prolactinomas effectively requires a personalized approach that considers individual patient needs and potential side effects.

Dr.Camel's Conclusion

This study underscores the importance of understanding and managing DA intolerance in patients with prolactinomas.

Date :
  1. Date Completed 2023-06-09
  2. Date Revised 2023-06-09
Further Info :

Pubmed ID

37027090

DOI: Digital Object Identifier

10.1007/s11102-023-01313-8

Related Literature

Article Analysis
・Side Effects of cabergoline
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.